找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiorenal Syndrome; Mechanisms, Risk and Adel E. Berbari,Giuseppe Mancia Book 2010 Springer-Verlag Milan 2010 Chronic kidney disease.card

[復(fù)制鏈接]
樓主: T-cell
21#
發(fā)表于 2025-3-25 04:47:27 | 只看該作者
Discussion And Conclusion Of The Study,iorenal association and to pinpoint features that are specific to each clinical entity, whether the initial insult is renal or cardiac. A detailed discussion of the various aspects of cardiorenal association are well covered in the following chapters.
22#
發(fā)表于 2025-3-25 10:59:49 | 只看該作者
Novice Writers and Scholarly Publication 88% of patients with chronic kidney disease never reach end-stage renal disease, as the majority of them die due to cardiovascular disease. Thus, understanding the role of renal parenchymal disease as an independent cardiovascular risk state — i.e., renocardiac syndrome — is very important. In this
23#
發(fā)表于 2025-3-25 12:35:01 | 只看該作者
24#
發(fā)表于 2025-3-25 17:50:13 | 只看該作者
Novice Writers and Scholarly Publicationardiovascular events can be prevented. As the cardiorenal process advances, atherosclerotic vascular damage progresses, and subclinical organ damage can be detected. Chronic kidney disease is included at this stage, and a number of conditions associated with renal dysfunction become novel risk facto
25#
發(fā)表于 2025-3-25 22:43:58 | 只看該作者
https://doi.org/10.1007/978-3-662-28359-2lanation as to why increased albuminuria not only predicts renal disease risk but also CVD risk. Treatments that lower albuminuria are associated with cardiovascular protection, as demonstrated in randomized controlled trials of diabetic as well as hypertensive patients. There is preliminary evidenc
26#
發(fā)表于 2025-3-26 03:59:42 | 只看該作者
https://doi.org/10.1007/978-3-030-89877-9and vascular damage. In addition, the chapter reviews trial data that evaluated microalbuminuria for its prognostic significance on cardiovascular outcomes, as well as existing therapeutic interventions for reducing urinary albumin excretion in patients with high cardiovascular risk.
27#
發(fā)表于 2025-3-26 08:20:06 | 只看該作者
28#
發(fā)表于 2025-3-26 09:07:45 | 只看該作者
Progress in Inflammation Research lipid abnormalities. Beta blockers, aspirin and angiotensinconverting (ACE) inhibitors are likely effective therapies for treating coronary artery disease (CAD), but these remain very much underutilized. Similarly, despite evidence that coronary revascularization is useful in CKD and dialysis patie
29#
發(fā)表于 2025-3-26 14:21:19 | 只看該作者
Strategies for Deep Customer Engagement, condition of this deadly syndrome, sometimes also called cardiorenal-anemia syndrome. In patients with heart failure, renal function has a powerful prognostic significance. This is true both in chronic heart failure over a long follow-up and in acutely decompensated heart failure for in-hospital mo
30#
發(fā)表于 2025-3-26 20:52:25 | 只看該作者
everal uremia related factors such as uncontrolled hypertension, disturbed glucose insulin metabolism, microalbuminuria, phosphate retention, secondary hyperparathyroidism, myocardial and vascular calcification978-88-470-5609-1978-88-470-1463-3
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-23 01:05
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
SHOW| 揭西县| 洛隆县| 缙云县| 砚山县| 叶城县| 阿拉善右旗| 资中县| 茶陵县| 黑龙江省| 静乐县| 房产| 甘洛县| 芦溪县| 克山县| 二手房| 荥阳市| 峨边| 焦作市| 务川| 鄂尔多斯市| 大姚县| 宜丰县| 临城县| 肇庆市| 玉龙| 新余市| 隆子县| 突泉县| 璧山县| 商南县| 石林| 阳城县| 荆州市| 兴仁县| 武功县| 南和县| 呼玛县| 鹤山市| 孝感市| 定安县|